These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6697364)

  • 41. Tuberculosis therapy and enzyme induction in man.
    Larousse C; Le Normand Y; Kergueris MF; Veyrac MJ; Chailleux E; Ordronneau J; Moigneteau C
    Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):163-8. PubMed ID: 7380590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Isoniazid concentrations in the blood, resected lung tissue and the gallbladder bed in relation to the method of administration to pulmonary tuberculosis patients with stomach and liver diseases].
    Androsov EE; Vinokurov VA; Garvalinskiĭ GF; Karita VR; Pogrebinskiĭ MB
    Antibiotiki; 1984 Sep; 29(9):671-3. PubMed ID: 6508257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Isoniazid metabolism and the indicators of bioelectric activity of the brain in patients with tuberculosis during treatment with increased doses of isoniazid].
    Vilenskaia RN; Chelnokova NV
    Probl Tuberk; 1976; 3():46-9. PubMed ID: 967856
    [No Abstract]   [Full Text] [Related]  

  • 44. [Ratio of slow and fast isoniazide inactivators in the Czech and Slovak population (author's transl)].
    Víznerová A; Polanský F; Slavíková Z
    Cas Lek Cesk; 1974 Jun; 113(24):723-5. PubMed ID: 4451958
    [No Abstract]   [Full Text] [Related]  

  • 45. [Determination of acetylator phenotype of isoniazid by superimposed sinusodial tension polarography].
    Vallon JJ; Badinand A; Bichon C
    Eur J Toxicol Environ Hyg; 1976; 9(3):155-64. PubMed ID: 954852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determination of acetylator phenotype based on the ratio of acetylisoniazid to isoniazid in urine following an oral dose of ordinary isoniazid.
    Raghupati Sarma G; Kannapirin G; Narayana AS; Radhakrishna S; Tripathy SP
    Indian J Med Res; 1976 Jan; 64(1):1-8. PubMed ID: 1270091
    [No Abstract]   [Full Text] [Related]  

  • 47. [Distribution and elimination of isoniazid-H3 in pulmonary tuberculosis patients].
    Bondarev IM; Vasil'ev NA; Cherednichenko LP
    Probl Tuberk; 1970; 48(3):65-9. PubMed ID: 5453153
    [No Abstract]   [Full Text] [Related]  

  • 48. [Peculiarities of PAS and tubazid metabolism in tuberculous patients treated with nerobol and ATP].
    Sabula MM
    Probl Tuberk; 1972; 50(1):47-50. PubMed ID: 5010779
    [No Abstract]   [Full Text] [Related]  

  • 49. [Use of ethamide in complex treatment of pulmonary tuberculosis].
    Bilyk MA; Dudchik GKh
    Vrach Delo; 1976 Nov; (11):109-10. PubMed ID: 1014536
    [No Abstract]   [Full Text] [Related]  

  • 50. [The significance of INH metabolism analysis for therapy. II].
    Mydlak G; Volkmann W
    Z Tuberk Erkr Thoraxorg; 1965 Nov; 124(1):44-8. PubMed ID: 5899093
    [No Abstract]   [Full Text] [Related]  

  • 51. Isoniazid inactivation in Indian children.
    Desai M; Jariwala G; Khokhani B; Desai NK; Sheth UK
    Indian Pediatr; 1973 Jun; 10(6):373-6. PubMed ID: 4746249
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evaluation of the isoniazid dosimetry which uses a rapid and simple technic for the determination of the acetylator phenotype].
    Kergueris MF; Le Normand Y; Veyrac MJ; Ortega A; Larousse C
    Therapie; 1978; 33(6):735-42. PubMed ID: 746520
    [No Abstract]   [Full Text] [Related]  

  • 53. [Isoniazid inactivation in 2 ethnic groups].
    Kasenov KU; Baĭnasheva TI
    Probl Tuberk; 1984 Nov; (11):18-20. PubMed ID: 6240656
    [No Abstract]   [Full Text] [Related]  

  • 54. [Study of the acetylator phenotype in Andalusia].
    Saucedo Sánchez R; Mayor Morente B; Puche Cañas E
    Rev Clin Esp; 1985 Jun; 177(2):75-7. PubMed ID: 4048566
    [No Abstract]   [Full Text] [Related]  

  • 55. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Metabolism of isoniazid in humans. Reflexions of a practical nature].
    Fantoli U
    Lotta Tuberc; 1966; 36(7):231-45. PubMed ID: 5235940
    [No Abstract]   [Full Text] [Related]  

  • 57. [Mechanism of excretion of HINA metabolites by the kidneys of patients with pulmonary tuberculosis].
    Dudckik GKh; Bilyk MA
    Probl Tuberk; 1975; (5):57-61. PubMed ID: 1144347
    [No Abstract]   [Full Text] [Related]  

  • 58. [HPLC study of blood isoniazid in patients with tuberculosis in Tunisia: significance and therapeutic results].
    Barhoumi C; Masmoudi AS; Gritli N; Hamza M; Nsiri B; Amor A; Mechghoul S; Belhadj O
    Tunis Med; 1995 Oct; 73(10):379-84. PubMed ID: 9506162
    [No Abstract]   [Full Text] [Related]  

  • 59. Screening of isoniazid inactivators by dilution test.
    Hodgkin MM; Eidus L; Hamilton EJ
    Bull World Health Organ; 1974; 51(4):428-30. PubMed ID: 4549494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Acetylation phenotype and its clinical significance].
    Orzechowska-Juzwenko K; Milejski P
    Pol Tyg Lek; 1982 Nov; 37(45):1365-7. PubMed ID: 7163093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.